Spyre Therapeutics (SYRE) Q1 2020 Earnings

7MayExpected
Q2 2019
Q3 2019
Q4 2019
Q1 2020
-16.5
-11.16
-5.82
-0.48

Details

Expected EPS
-0.65
Actual EPS
-14.25
Surprise EPS
-13.6
Surprise Percent
+2,092.31%

Description

Spyre Therapeutics (SYRE) has reported earnings of -14.25 per share for Q1 2020.

0 Comments

Share your thoughts